Oragenics Inc

8-K

Oragenics signs a Letter of Intent to license CardioDialysis technology from Sigyn Therapeutics to target Traumatic Brain Injury-induced systemic inflammation. The agreement will position Oragenics as the only company with therapeutic strategies targeting inflammation. Oragenics expects to issue 3.25M shares.

Oragenics Inc OGEN is headquartered in Lakewood Ranch, FL.

Source

Posted May 7, 2026, 12:34 PM UTC